Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 13Other hematologic neoplasm 4Plasma cell 2Myeloid 2Genitourinary 2Dermatologic 2CNS 2Thoracic 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 8Adenocarcinoma of Lung 5Adenocarcinoma, Bronchiolo-Alveolar 3Small Cell Lung Carcinoma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1HIV Infections 1

Interventions

pembrolizumab 8Nivolumab 6Gemcitabine 5spartalizumab 3Magnetic Resonance Spectroscopy 3Cyclophosphamide 3Azacitidine 3toripalimab 2fludarabine 2epacadostat 2atezolizumab 2Therapeutics 2Sirolimus 2Paclitaxel 2Interleukin-2 2Epoetin Alfa 2Cisplatin 2Bevacizumab 2vocimagene amiretrorepvec 1vandetanib 1ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1tislelizumab 1temsirolimus 1sargramostim 1sapanisertib 1ruxolitinib 1rucaparib 1romidepsin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma × Amplified Fragment Length Polymorphism Analysis × Thoracic × Clear all
NCT01567722 2023-03-16

Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies

AIDS Malignancy Consortium

Terminated
114 enrolled 8 charts
LymphoidThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Lymphoma, HIV Infections, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡